Evidence map›Paper›PMID 34468549›Full record

ReviewRevista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)

A narrative review on invasive brain stimulation for treatment-resistant depression.

Manoj P Dandekar, Alexandre P Diaz, Ziaur Rahman, Ritele H Silva, Ziad Nahas, Scott Aaronson, Sudhakar Selvaraj, Albert J Fenoy, Marsal Sanches, Jair C Soares and 2 more

Open access · diamondAbstract readReview
In one paragraph

Review in Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Conflicts of interest in invasive brain stimulation research.Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 3 countries.

Manoj P DandekarDepartment of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research, Hyderabad, Telangana, India.
Alexandre P DiazCenter of Excellence on Mood Disorders, Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA.ORCID http://orcid.org/0000-0002-6591-6648
Ziaur RahmanDepartment of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research, Hyderabad, Telangana, India.
Ritele H SilvaLaboratório de Psiquiatria Translacional, Programa de Pós-Graduação em Ciências da Saúde, Universidade do Extremo Sul Catarinense (UNESC), Criciúma, SC, Brazil.
Ziad NahasDepartment of Psychiatry and Behavioral Sciences, University of Minnesota, Minneapolis, MN, USA.
Scott AaronsonClinical Research Programs, Sheppard Pratt Health System, Baltimore, MD, USA.
Sudhakar SelvarajCenter of Excellence on Mood Disorders, Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA.ORCID http://orcid.org/0000-0002-9494-172X
Albert J FenoyCenter of Excellence on Mood Disorders, Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA.ORCID http://orcid.org/0000-0002-9554-9885
Marsal SanchesCenter of Excellence on Mood Disorders, Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA.
Jair C SoaresCenter of Excellence on Mood Disorders, Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA.
Patricio Riva-PosseDepartment of Psychiatry and Behavioral Sciences, Emory University, Atlanta, GA, USA.
Joao QuevedoCenter of Excellence on Mood Disorders, Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA.ORCID http://orcid.org/0000-0003-3114-6611
The University of Texas Health Science Center at Houston · USNational Institute of Pharmaceutical Education and Research · INThe University of Texas MD Anderson Cancer Center · USEmory University · USSheppard Pratt Health System · USThe University of Texas Health Science Center · USUniversidade do Extremo Sul Catarinense · BRUniversity of Minnesota · US

Funding

Neural-derived extracellular vesicles microRNAs in bipolar disorder: a peripheral window into the brainR21MH117636 · NIMH · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI DE QUEVEDO, JOAO L · 2019 to 2020
$387k
NIMH NIH HHS R21 MH117636
6 · The paper itself

Abstract

While most patients with depression respond to pharmacotherapy and psychotherapy, about one-third will present treatment resistance to these interventions. For patients with treatment-resistant depression (TRD), invasive neurostimulation therapies such as vagus nerve stimulation, deep brain stimulation, and epidural cortical stimulation may be considered. We performed a narrative review of the published literature to identify papers discussing clinical studies with invasive neurostimulation therapies for TRD. After a database search and title and abstract screening, relevant English-language articles were analyzed. Vagus nerve stimulation, approved by the U.S. Food and Drug Administration as a TRD treatment, may take several months to show therapeutic benefits, and the average response rate varies from 15.2-83%. Deep brain stimulation studies have shown encouraging results, including rapid response rates (> 30%), despite conflicting findings from randomized controlled trials. Several brain regions, such as the subcallosal-cingulate gyrus, nucleus accumbens, ventral capsule/ventral striatum, anterior limb of the internal capsule, medial-forebrain bundle, lateral habenula, inferior-thalamic peduncle, and the bed-nucleus of the stria terminalis have been identified as key targets for TRD management. Epidural cortical stimulation, an invasive intervention with few reported cases, showed positive results (40-60% response), although more extensive trials are needed to confirm its potential in patients with TRD.

Indexed as

Deep Brain StimulationDepressive Disorder, Treatment-ResistantBrainDepressionHumansPsychotherapy

Identifiers

PMID34468549
PMCPMC9169472
OpenAlexW3196667749

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.